Robert Barrow, CEO: Definium Therapeutics DFTX Sell · Filed 23/03/02

Trade details

Type: Insider sale
Amount: $29,038.23
Shares · price: 8,273 sh · $3.51 a share
Held after: 238,959 sh
Stock: Definium Therapeutics DFTX
Person: Robert BarrowCEO
Trade date: 23/03/01
Filed: 23/03/02
Days to filing: 1 days

Sold 3.3% of holdings

Share of holding sold: 3.3%

Definium Therapeutics trades, last 26 weeks

What else happened in Definium Therapeutics around then

Filed or reported within 30 days of the trade day · 23/01/30~23/03/31

Robert Barrow's recent trades

Robert BarrowCEO
Sell10b5-1 planDefinium Therapeutics
Sell10b5-1 plan
Definium Therapeutics
DFTX
$1.2M
31,550 sh
$1.2M
Filed 09/29
Traded 09/25
Robert BarrowCEO
Planned saleDefinium Therapeutics
Planned sale
Definium Therapeutics
DFTX
$1.2M
31,550 sh
$1.2M
Filed 09/25
Traded 09/25
Robert BarrowCEO
Planned saleDefinium Therapeutics
Planned sale
Definium Therapeutics
DFTX
$718.1K
19,023 sh
$718.1K
Filed 09/03
Traded 09/03
Robert BarrowCEO
Sell10b5-1 planDefinium Therapeutics
Sell10b5-1 plan
Definium Therapeutics
DFTX
$1.3M
29,208 sh
$1.3M
Filed 06/26
Traded 06/25
Robert BarrowCEO
Planned saleDefinium Therapeutics
Planned sale
Definium Therapeutics
DFTX
$1.2M
29,208 sh
$1.2M
Filed 06/25
Traded 06/25